Contemporary management of acoustic neuromas

Laryngoscope

Volumn 121, Issue 6, 2011, Pages 1133-1137

  Theodosopoulos, Philip V ^a   Pensak, Myles L ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Acoustic neuroma; Outcomes; Vestibular schwannoma

Indexed keywords

BEVACIZUMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; LAPATINIB; OSU 030312; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ACOUSTIC NEURINOMA; BRAIN DECOMPRESSION; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COCHLEA; COST EFFECTIVENESS ANALYSIS; CRANIOTOMY; CYTOREDUCTIVE SURGERY; EVIDENCE BASED MEDICINE; EXTRACELLULAR MATRIX; FACIAL NERVE; FACIAL NERVE DISEASE; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; HUMAN; HYDROCEPHALUS; LIQUORRHEA; MICROARRAY ANALYSIS; MICROSURGERY; MULTIMODALITY CANCER THERAPY; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIOSURGERY; REVIEW; STEREOTACTIC RADIOSURGERY; TINNITUS; TREATMENT FAILURE; TREATMENT OUTCOME;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; HUMANS; MICROSURGERY; NEUROMA, ACOUSTIC; OTORHINOLARYNGOLOGIC SURGICAL PROCEDURES; RADIOSURGERY; RADIOTHERAPY DOSAGE; REOPERATION; TREATMENT OUTCOME;

EID: 79958293901     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.21799     Document Type: Review

References (57)

1. Nikolopoulos TP, Fortnum H, O'Donoghue G, Baguley D. Acoustic neuroma growth: a systematic review of the evidence. Otol Neurotol 2010; 31:478-485.
2. Pollock BE, Link MJ, Foote RL. Failure rate of contemporary low-dose radiosurgical technique for vestibular schwannoma. J Neurosurg 2009; 111:840-844.
3. Liscak R, Vladyka V, Urgosik D, Simonova G, Vymazal J. Repeated treatment of vestibular schwannomas after gamma knife radiosurgery. Acta Neurochir (Wien) 2009;151:317-324.
4. Kano H, Kondziolka D, Niranjan A, Flannery TJ, Flickinger JC, Lunsford LD. Repeat stereotactic radiosurgery for acoustic neuromas. Int J Radiat Oncol Biol Phys 2010;76:520-527.
5. Combs SE, Thilmann C, Debus J, Schulz-Ertner D. Long-term outcome of stereotactic radiosurgery (SRS) in patients with acoustic neuromas. Int J Radiat Oncol Biol Phys 2006;64:1341-1347.
6. Combs SE, Welzel T, Schulz-Ertner D, Huber PE, Debus J. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas. Int J Radiat Oncol Biol Phys 2010;76:193-200.
7. Beegle RD, Friedman WA, Bova FJ. Effect of treatment plan quality on outcomes after radiosurgery for vestibular schwannoma. J Neurosurg 2007;107:913-916. (Pubitemid 350255202)
8. Bush ML, Shinn JB, Young AB, Jones RO. Long-term hearing results in gamma knife radiosurgery for acoustic neuromas. Laryngoscope 2008; 118:1019-1022. (Pubitemid 351787272)
9. Friedman WA, Bradshaw P, Myers A, Bova FJ. Linear accelerator radiosurgery for vestibular schwannomas. J Neurosurg 2006;105:657-661. (Pubitemid 44703923)
10. Hasegawa T, Kida Y, Yoshimoto M, Koike J, Goto K. Evaluation of tumor expansion after stereotactic radiosurgery in patients harboring vestibular schwannomas. Neurosurgery 2006;58:1119-1128.
11. Ju DT, Lin JW, Lin MS, et al. Hypofractionated CyberKnife stereotactic radiosurgery for acoustic neuromas with and without association to neurofibromatosis Type 2. Acta Neurochir Suppl 2008;101:169-173.
12. Koh ES, Millar BA, Menard C, et al. Fractionated stereotactic radiotherapy for acoustic neuroma: single-institution experience at The Princess Margaret Hospital. Cancer 2007;109:1203-1210. (Pubitemid 46435401)
13. Lin YC, Wang CC, Wai YY, et al. Significant temporal evolution of diffusion anisotropy for evaluating early response to radiosurgery in patients with vestibular schwannoma: findings from functional diffusion maps. AJNR Am J Neuroradiol 2010;31:269-274.
14. Maire JP, Huchet A, Milbeo Y, et al. Twenty years' experience in the treatment of acoustic neuromas with fractionated radiotherapy: a review of 45 cases. Int J Radiat Oncol Biol Phys 2006;66:170-178. (Pubitemid 44175663)
15. Massager N, Nissim O, Delbrouck C, et al. Irradiation of cochlear structures during vestibular schwannoma radiosurgery and associated hearing outcome. J Neurosurg 2007;107:733-739. (Pubitemid 47547735)
16. Phi JH, Kim DG, Chung HT, Lee J, Paek SH, Jung HW. Radiosurgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2: tumor control and hearing preservation. Cancer 2009;115:390-398.
17. Pollock BE. Management of vestibular schwannomas that enlarge after stereotactic radiosurgery: treatment recommendations based on a 15 year experience. Neurosurgery 2006;58:241-248.
18. Sasagawa Y, Akai T, Itou S, Iizuka H. Gamma knife radiosurgery-induced cavernous hemangioma: case report. Neurosurgery 2009;64:1006-1007.
19. Tamura M, Carron R, Yomo S, et al. Hearing preservation after gamma knife radiosurgery for vestibular schwannomas presenting with highlevel hearing. Neurosurgery 2009;64:289-296.
20. Thomas C, Di Maio S, Ma R, et al. Hearing preservation following fractionated stereotactic radiotherapy for vestibular schwannomas: prognostic implications of cochlear dose. J Neurosurg 2007;107:917-926. (Pubitemid 350255203)
21. Timmer FC, Hanssens PE, van Haren AE, et al. Gamma knife radiosurgery for vestibular schwannomas: results of hearing preservation in relation to the cochlear radiation dose. Laryngoscope 2009;119:1076-1081.
22. Weber DC, Chan AW, Bussiere MR, et al. Proton beam radiosurgery for vestibular schwannoma: tumor control and cranial nerve toxicity. Neurosurgery 2003;53:577-586.
23. Weil RS, Cohen JM, Portarena I, et al. Optimal dose of stereotactic radiosurgery for acoustic neuromas: A systematic review. Br J Neurosurg 2006;20:195-202. (Pubitemid 44358972)
24. Wentworth S, Pinn M, Bourland JD, et al. Clinical experience with radiation therapy in the management of neurofibromatosis-associated central nervous system tumors. Int J Radiat Oncol Biol Phys 2008;73:208-213.
25. Yang I, Sughrue ME, Han SJ, et al. Facial nerve preservation after vestibular schwannoma Gamma Knife radiosurgery. J Neurooncol 2009;93: 41-48.
26. Yomo S, Arkha Y, Delsanti C, Roche PH, Thomassin JM, Regis J. Repeat gamma knife surgery for regrowth of vestibular schwannomas. Neurosurgery 2009;64:48-54.
27. Ammoun S, Cunliffe CH, Allen JC, et al. ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma. Neuro Oncol 2010;12:834-843.
28. Doherty JK, Ongkeko W, Crawley B, Andalibi A, Ryan AF. ErbB and Nrg: potential molecular targets for vestibular schwannoma pharmacotherapy. Otol Neurotol 2008;29:50-57.
29. Hansen MR, Clark JJ, Gantz BJ, Goswami PC. Effects of ErbB2 signaling on the response of vestibular schwannoma cells to gamma-irradiation. Laryngoscope 2008;118:1023-1030. (Pubitemid 351787273)
30. Lee TX, Packer MD, Huang J, et al. Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells. Eur J Cancer 2009;45:1709-1720.
31. Plotkin SR, Halpin C, Blakeley JO, et al. Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma. J Neurooncol 2009;93:61-77.
32. Gouveris H, Mann W. Association between surgical steps and intraoperative auditory brainstem response and electrocochleography waveforms during hearing preservation vestibular schwannoma surgery. Eur Arch Otorhinolaryngol 2009;266:225-229.
33. Cheng S, Naidoo Y, da Cruz M, Dexter M. Quality of life in postoperative vestibular schwannoma patients. Laryngoscope 2009;119:2252-2257.
34. Akard W, Tubbs RS, Seymour ZA, Hitselberger WE, Cohen-Gadol AA. Evolution of techniques for the resection of vestibular schwannomas: from saving life to saving function. J Neurosurg 2009;110:642-647.
35. Bacciu A, Falcioni M, Pasanisi E, et al. Intracranial facial nerve grafting after removal of vestibular schwannoma. Am J Otolaryngol 2009;30:83-88.
36. Bakkouri WE, Kania RE, Guichard JP, Lot G, Herman P, Huy PT. Conservative management of 386 cases of unilateral vestibular schwannoma: tumor growth and consequences for treatment. J Neurosurg 2009;110:662-669.
37. Barker FG 2nd, Carter BS, Ojemann RG, Jyung RW, Poe DS, McKenna MJ. Surgical excision of acoustic neuroma: patient outcome and provider caseload. Laryngoscope 2003;113:1332-1343. (Pubitemid 36944675)
38. Catli T, Bayazit YA, Gokdogan O, Goksu N. Facial reanimation with end-to-end hypoglossofacial anastomosis: 20 years' experience. J Laryngol Otol 2010;124:23-25.
39. Esquia-Medina GN, Grayeli AB, Ferrary E, et al. Do facial nerve displacement pattern and tumor adhesion influence the facial nerve outcome in vestibular schwannoma surgery? Otol Neurotol 2009;30:392-397.
40. Hastan D, Vandenbroucke JP, van der Mey AG. A meta-analysis of surgical treatment for vestibular schwannoma: Is hospital volume related to preservation of facial function? Otol Neurotol 2009;30:975-980.
41. Iwai Y, Yamanaka K, Yamagata K, Yasui T. Surgery after radiosurgery for acoustic neuromas: surgical strategy and histological findings. Neurosurgery 2007;60(suppl 1):ONS75-82.
42. Myrseth E, Moller P, Pedersen PH, Lund-Johansen M. Vestibular schwannoma: surgery or gamma knife radiosurgery? A prospective, nonrandomized study. Neurosurgery 2009;64:654-661.
43. Pollock BE, Driscoll CL, Foote RL, et al. Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery 2006;59:77-85.
44. Raftopoulos C, Abu Serieh B, Duprez T, Docquier MA, Guerit JM. Microsurgical results with large vestibular schwannomas with preservation of facial and cochlear nerve function as the primary aim. Acta Neurochir (Wien) 2005;147:697-706. (Pubitemid 40853779)
45. Sasaki T, Shono T, Hashiguchi K, Yoshida F, Suzuki SO. Histological considerations of the cleavage plane for preservation of facial and cochlear nerve functions in vestibular schwannoma surgery. J Neurosurg 2009; 110:648-655.
46. Shuto T, Inomori S, Matsunaga S, Fujino H. Microsurgery for vestibular schwannoma after gamma knife radiosurgery. Acta Neurochir (Wien) 2008;150:229-234.
47. Stieglitz LH, Wrede KH, Gharabaghi A, et al. Factors affecting postoperative cerebrospinal fluid leaks after retrosigmoidal craniotomy for vestibular schwannomas. J Neurosurg 2009;111:874-883.
48. von Eckardstein KL, Beatty CW, Driscoll CL, Link MJ. Spontaneous regression of vestibular schwannomas after resection of contralateral tumor in neurofibromatosis Type 2. J Neurosurg 2010;112:158-162.
49. Wanibuchi M, Fukushima T, McElveen JT Jr, Friedman AH. Hearing preservation in surgery for large vestibular schwannomas. J Neurosurg 2009;111:845-854.
50. Hajioff D, Raut VV, Walsh RM, et al. Conservative management of vestibular schwannomas: third review of a 10-year prospective study. Clin Otolaryngol 2008;33:255-259. (Pubitemid 351799012)
51. Sughrue ME, Yang I, Aranda D, et al. The natural history of untreated sporadic vestibular schwannomas: a comprehensive review of hearing outcomes. J Neurosurg 2010;112:163-167.
52. Stangerup SE, Thomasen J, Tos M, Caye-Thomasen P. Long-term preservation in vestibular schwannoma. Otol Neurotol 2010;31:271-275.
53. Chen DA. Acoustic neuroma in a private neurotology practice: trends in demographics and practice patterns. Laryngoscope 2007;117:2003-2012. (Pubitemid 350059383)
54. Banerjee R, Moriarty JP, Foote RL, Pollock BE. Comparison of the surgical and follow-up costs associated with microsurgical resection and stereotactic radiosurgery for vestibular schwannoma. J Neurosurg 2008;108: 1220-1224. (Pubitemid 351798500)
55. Kameda K, Shono T, Hashiguchi K, Yoshida F, Sasaki T. Effect of tumor removal on tinnitus in patients with vestibular schwannoma. J Neurosurg 2010;112:152-157.
56. Caye-Thomasen P, Borup R, Stangerup SE, Thomasen J, Nielsen FC. Deregulated genes in sporadic vestibular schwannomas. Otol Neurotol 2010;31:256-266.
57. Plotkin SR, Stemmer-Rachamimov AO, Barker FG 2nd et al. Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med 2009;361:358-367.